Metabolic Disorders

Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases

Drug	Drug Name	Drug Description
DB00437	Allopurinol	A xanthine oxidase inhibitor used to reduce urinary and serum uric acid concentrations in patients with gout, recurrent calcium oxalate calculi, and various malignancies.
DB00140	Riboflavin	A vitamin used to correct vitamin B2 deficiency.

Drug	Drug Name	Target	Type
DB00437	Allopurinol	Xanthine dehydrogenase/oxidase	target
DB00437	Allopurinol	Organic anion transporter 3	transporter
DB00437	Allopurinol	Solute carrier family 22 member 7	transporter
DB00437	Allopurinol	Aldehyde oxidase	enzyme
DB00437	Allopurinol	Xanthine dehydrogenase/oxidase	enzyme
DB00437	Allopurinol	Broad substrate specificity ATP-binding cassette transporter ABCG2	transporter
DB00437	Allopurinol	Solute carrier family 22 member 2	transporter
DB00140	Riboflavin	Flavin reductase (NADPH)	target
DB00140	Riboflavin	Riboflavin kinase	target
DB00140	Riboflavin	Riboflavin synthase	target
DB00140	Riboflavin	Amine oxidase [flavin-containing] A	enzyme
DB00140	Riboflavin	Methylenetetrahydrofolate reductase (NADPH)	enzyme
DB00140	Riboflavin	Solute carrier family 22 member 6	transporter

Drug	Drug Name	Phase	Status	Count
DB15354	Evinacumab	1	Completed	1
DB04974	Rimiducid	1	Terminated	1
DB19107	Rivogenlecleucel	1	Terminated	1
DB05528	Mipomersen	2	Completed	3
DB01109	Heparin	3	Terminated	1
DB00999	Hydrochlorothiazide	3	Completed	1
DB00678	Losartan	3	Completed	1
DB05528	Mipomersen	3	Completed	2
DB09038	Empagliflozin	Not Available	Not Yet Recruiting	1
DB00331	Metformin	Not Available	Not Yet Recruiting	1